FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.4  |  FHIR Version n/a  User: [n/a]

65334011000036108: Blistex Medicated Lip (camphor 10 mg / 1 g + oxybenzone 20 mg / 1 g + padimate-O 75 mg / 1 g) ointment (trade product unit of use)

Status: current, Defined. Date: 30-Jun 2009. Module: Australian Medicines Terminology module

Descriptions:

Id Description Lang Type Status Case? Module
393079011000036110 Blistex Medicated Lip (camphor 10 mg / 1 g + oxybenzone 20 mg / 1 g + padimate-O 75 mg / 1 g) ointment (trade product unit of use) en Fully specified name Active Case sensitive Australian Medicines Terminology module
393080011000036110 Blistex Medicated Lip ointment en Synonym Active Case sensitive Australian Medicines Terminology module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Blistex Medicated Lip ointment has intended active ingredient padimate-O true Inferred relationship Some 223917168
Blistex Medicated Lip ointment has intended active ingredient oxybenzone true Inferred relationship Some 1345664926
Blistex Medicated Lip ointment has manufactured dose form ointment true Inferred relationship Some
Blistex Medicated Lip ointment Is a trade product unit of use true Inferred relationship Some
Blistex Medicated Lip ointment Is a Blistex Medicated Lip true Inferred relationship Some
Blistex Medicated Lip ointment Is a padimate-O 7.5% + oxybenzone 2% + camphor 1% ointment true Inferred relationship Some
Blistex Medicated Lip ointment has Australian BoSS camphor true Inferred relationship Some 991648898
Blistex Medicated Lip ointment has Australian BoSS padimate-O true Inferred relationship Some 223917168
Blistex Medicated Lip ointment has Australian BoSS oxybenzone true Inferred relationship Some 1345664926
Blistex Medicated Lip ointment has unit of use continuous true Inferred relationship Some 1345664927
Blistex Medicated Lip ointment has intended active ingredient camphor true Inferred relationship Some 991648898
Inbound Relationships Type Active Source Characteristic Refinability Group
Blistex Medicated Lip ointment, 2.25 g has TPUU True Blistex Medicated Lip ointment Inferred relationship Some 1
Blistex Medicated Lip ointment, 8 g has TPUU True Blistex Medicated Lip ointment Inferred relationship Some 1
Blistex Medicated Lip ointment, 6 g has TPUU True Blistex Medicated Lip ointment Inferred relationship Some 1
Blistex Medicated Lip ointment, 6 g, tube has TPUU True Blistex Medicated Lip ointment Inferred relationship Some 1
Blistex Medicated Lip ointment, 8 g, tube has TPUU True Blistex Medicated Lip ointment Inferred relationship Some 1
Blistex Medicated Lip ointment, 2.25 g, tube has TPUU True Blistex Medicated Lip ointment Inferred relationship Some 1

Reference Sets

Trade product unit of use reference set

Back to Start